EYE CARE INTERNATIONAL INC
NT 10-K, 2000-03-31
OFFICES & CLINICS OF DOCTORS OF MEDICINE
Previous: WORLD AIRWAYS INC /DE/, S-8, 2000-03-31
Next: PHARMACIA & UPJOHN INC, 425, 2000-03-31




<PAGE>

                                 UNITED STATES
                        SECURITIES & EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  FORM 12b-25

                                                       SEC File Number 0-27889
                                                       CUSIP Number 301942 10 8

                          NOTIFICATION OF LATE FILING
                                  (Check One):

[x] Form 10-K and Form 10-KSB [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q and
    Form 10-QSB [ ] Form N-SAR


        For Period Ended:               DECEMBER 31, 1999

                [ ]     Transition Report of Form 10-K
                [ ]     Transition Report of Form 20-F
                [ ]     Transition Report of Form 11-K
                [ ]     Transition Report of Form 10-Q
                [ ]     Transition Report of Form N-SAR
                For the Transition Period Ended: ______________________________


Read Attached Instruction Sheet Before Preparing Form.  Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein

If the notification related to a portion of the filing checked above, identify
the Item(s) to which the notification relates

                                      N/A

PART 1 - REGISTRANT INFORMATION

Full Name of Registrant:                  Eye Care International, Inc.

Former Name If Applicable                 N/A

Address of Principal Executive Office
Street and Number):                       1511 North Westshore Blvd., Suite 925

City, State and Zip Code:                 Tampa, Florida 33607
PART II - RULES 12b-15 (b) and (c)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25 (b), the following
should be completed. (Check box if applicable).
<PAGE>

[x]  (a)   The reasons described in reasonable detail in Part III of this
           form could not be eliminated without unreasonable effort or expense;

[x]  (b)   The subject annual report or semi-annual report, transition report on
           Form 10-K or portion thereon will be filed on or before the
           fifteenth calendar day following the prescribed due date;

[ ]  (c)   The accountant's statement or other exhibit required by
           Rule 12b-25 (c) has been attached if applicable.

PART III - NARRATIVE

State below in reasonable detail the reasons why Form 10-K could not be filed
within the prescribed time period.

The Registrant has a small administrative staff. All of the information
necessary to complete the report, including the financial information, could not
be obtained on a timely basis, without unreasonable effort or expense.

PART IV - OTHER INFORMATION


(1) Name and telephone number of person to contact in regard to this
    notification

          Clark Marcus        (813)                   289-5552
- --------------------------------------------------------------------------------
           (Name)          (Area Code)             (Telephone No.)

(1) Have all other periodic reports require under section 13 or 15 (d) of the
Securities Exchange Act of 1934 or section 30 of the Investment Company Act of
1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer is no,
identify report(s).

                        [ x ] Yes               [   ] No

(1) Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earning statements to be included in the subject report or portion thereof?

                        [ x ] Yes               [   ] No

If so: attach an explanation of the anticipated change, both narratively and
quantitatively, and if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.

Eye Care International, Inc.

has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.


Date: March 30, 2000                  By: /s/ Clark A. Marcus
                                          -------------------------------------
                                          Clark A. Marcus
                                          President and Chief Executive Officer


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission